Advertisement
OtherChemotherapy, Antibiotics, and Gene Therapy

Disruption of ovarian cancer STAT3 and p38 signaling with a small molecule inhibitor of PTP4A3 phosphatase

John S. Lazo, Kelly N. Isbell, Sai Ashish Vasa, Danielle C. Llaneza, Ettore J. Rastelli, Peter Wipf and Elizabeth R. Sharlow
Journal of Pharmacology and Experimental Therapeutics January 10, 2023, JPET-AR-2022-001401; DOI: https://doi.org/10.1124/jpet.122.001401
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherChemotherapy, Antibiotics, and Gene Therapy

PTP4A3 and ovarian cancer

John S. Lazo, Kelly N. Isbell, Sai Ashish Vasa, Danielle C. Llaneza, Ettore J. Rastelli, Peter Wipf and Elizabeth R. Sharlow
Journal of Pharmacology and Experimental Therapeutics January 10, 2023, JPET-AR-2022-001401; DOI: https://doi.org/10.1124/jpet.122.001401
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement